WHO: Summary report of a High-Level Consultation: new influenza A (H1N1)
INTRODUCTION
1. In view of the threat posed by the current outbreak of new influenza A (H1N1), the
Director-General of the World Health Organization convened a High-Level Consultation for all
Member States at the start of the Sixty-second World Health Assembly.
2. The consultation provided an opportunity for Member States to share experiences, to discuss
lessons learnt, and to highlight the challenges that now confront the world community. The list of
main speakers and programme is given in the Annex.
Download summary report [pdf 44kb]
For more information on H1N1 situation, please visit www.PandemicFlu.gov
http://www.who.int/csr/resources/publications/swineflu/High_Level_Consultation_18_May_2009.pdf
Information on the effectiveness of facemasks and respirators for decreasing the risk of influenza infection in community settings is extremely limited. Thus, it is difficult to assess their potential effectiveness in decreasing the risk of novel influenza A (H1N1) virus transmission in these settings. In the absence of clear scientific data, the interim recommendations below have been developed on the basis of public health judgment, the historical use of facemasks and respirators in other settings for preventing transmission of influenza and other respiratory viruses, and on current information on the spread and severity of the novel influenza A (H1N1) virus.
In areas with confirmed human cases of novel influenza A (H1N1) virus infection, the risk for infection can be reduced through a combination of actions. No single action will provide complete protection, but an approach combining the following steps can help decrease the likelihood of transmission. These recommended actions are:
In addition, influenza antiviral medications are an important tool for the treatment and prevention of influenza, including novel H1N1.http://www.cdc.gov/h1n1flu/masks.htm